Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 - Iterum Therapeutics (NASDAQ:ITRM)
8 Articles
8 Articles
MARPAI REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
Company continues to drive towards profitability
Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 - Iterum Therapeutics (NASDAQ:ITRM)
DUBLIN and CHICAGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its second quarter 2024 financial results before the open of the U.S. financial markets on…
Nordstrom to Report Second Quarter 2024 Financial Results on August 27
SEATTLE, Aug. 6, 2024 /PRNewswire/ -- Nordstrom, Inc. (NYSE: JWN) announced that it will report its second quarter 2024 financial results after the close of the financial markets on Tuesday, August 27, 2024. The announcement will be followed by a…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






